DIN 02493918 — NAT-LENALIDOMIDE 25 MG
NAT-LENALIDOMIDE is a capsule of Lenalidomide marketed by NATCO PHARMA (CANADA) INC. The full Lenalidomide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02493918
- Brand name
- NAT-LENALIDOMIDE
- Active ingredient
- Lenalidomide
- Strength
- 25 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- MARKETED
- Drug class
- Immunomodulatory antineoplastic agent (IMiD)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lenalidomide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02507943 | APO-LENALIDOMIDE | 10 MG | CAPSULE | APOTEX INC | MARKETED |
| 02507951 | APO-LENALIDOMIDE | 15 MG | CAPSULE | APOTEX INC | MARKETED |
| 02507927 | APO-LENALIDOMIDE | 2.5 MG | CAPSULE | APOTEX INC | MARKETED |
| 02507978 | APO-LENALIDOMIDE | 20 MG | CAPSULE | APOTEX INC | MARKETED |
| 02507986 | APO-LENALIDOMIDE | 25 MG | CAPSULE | APOTEX INC | MARKETED |
| 02507935 | APO-LENALIDOMIDE | 5 MG | CAPSULE | APOTEX INC | MARKETED |
| 02506157 | JAMP LENALIDOMIDE | 10 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02506165 | JAMP LENALIDOMIDE | 15 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02506130 | JAMP LENALIDOMIDE | 2.5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02506173 | JAMP LENALIDOMIDE | 20 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02506181 | JAMP LENALIDOMIDE | 25 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02506149 | JAMP LENALIDOMIDE | 5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02493861 | NAT-LENALIDOMIDE | 10 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02493888 | NAT-LENALIDOMIDE | 15 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02493837 | NAT-LENALIDOMIDE | 2.5 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02493896 | NAT-LENALIDOMIDE | 20 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02493845 | NAT-LENALIDOMIDE | 5 MG | CAPSULE | NATCO PHARMA (CANADA) INC | MARKETED |
| 02483025 | REDDY-LENALIDOMIDE | 10 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02483033 | REDDY-LENALIDOMIDE | 15 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02484714 | REDDY-LENALIDOMIDE | 2.5 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02483041 | REDDY-LENALIDOMIDE | 20 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02483068 | REDDY-LENALIDOMIDE | 25 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02483017 | REDDY-LENALIDOMIDE | 5 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02304902 | REVLIMID | 10 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02317699 | REVLIMID | 15 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02459418 | REVLIMID | 2.5 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02440601 | REVLIMID | 20 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02317710 | REVLIMID | 25 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02304899 | REVLIMID | 5 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02518589 | SANDOZ LENALIDOMIDE | 10 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518597 | SANDOZ LENALIDOMIDE | 15 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518562 | SANDOZ LENALIDOMIDE | 2.5 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518600 | SANDOZ LENALIDOMIDE | 20 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518619 | SANDOZ LENALIDOMIDE | 25 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518570 | SANDOZ LENALIDOMIDE | 5 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02507889 | TARO-LENALIDOMIDE | 10 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02507897 | TARO-LENALIDOMIDE | 15 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02507862 | TARO-LENALIDOMIDE | 2.5 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02507900 | TARO-LENALIDOMIDE | 20 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02507919 | TARO-LENALIDOMIDE | 25 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |
| 02507870 | TARO-LENALIDOMIDE | 5 MG | CAPSULE | TARO PHARMACEUTICALS INC | MARKETED |